Your browser doesn't support javascript.
loading
Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals.
Al-Kuraishy, Hayder M; Batiha, Gaber El-Saber; Faidah, Hani; Al-Gareeb, Ali I; Saad, Hebatallah M; Simal-Gandara, Jesus.
  • Al-Kuraishy HM; Department of Clinical Pharmacology and Medicine, College of Medicine, ALmustansiriyia University, M.B.Ch.B, FRCP, Baghdad, Iraq.
  • Batiha GE; Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour, 22511, AlBeheira, Egypt. gaberbatiha@gmail.com.
  • Faidah H; Microbiolgy Department Faculty of Medicine, Umm Al Qura University, Mecca, Saudi Arabia.
  • Al-Gareeb AI; Department of Clinical Pharmacology and Medicine, College of Medicine, ALmustansiriyia University, M.B.Ch.B, FRCP, Baghdad, Iraq.
  • Saad HM; Department of Pathology, Faculty of Veterinary Medicine, Matrouh University, Matrouh, 51744, Matrouh, Egypt. heba.magdy@mau.edu.eg.
  • Simal-Gandara J; Nutrition and Bromatology Group, Department of Analytical Chemistry and Food Science, Faculty of Science, Universidade de Vigo, E-32004, Ourense, Spain. jsimal@uvigo.es.
Inflammopharmacology ; 30(6): 2017-2026, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36044102
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrosis Pulmonar / Síndrome de Dificultad Respiratoria / Lesión Pulmonar Aguda / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrosis Pulmonar / Síndrome de Dificultad Respiratoria / Lesión Pulmonar Aguda / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article